98 related articles for article (PubMed ID: 8477561)
1. Decreased angiotensin II response but unaltered cardiovascular pressor response to infused norepinephrine after sodium restriction and converting enzyme inhibition.
Mills PJ; Dimsdale JE; Ziegler MG; Nelesen RA; Brown MR
Clin Pharmacol Ther; 1993 Apr; 53(4):450-6. PubMed ID: 8477561
[TBL] [Abstract][Full Text] [Related]
2. Sympathetic alterations after sodium restriction and short-term captopril administration.
Mills PJ; Dimsdale JE; Ziegler MG; Hauger RL; Nelesen RA; Brown MR
J Am Coll Cardiol; 1993 Jan; 21(1):177-81. PubMed ID: 8380185
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
[TBL] [Abstract][Full Text] [Related]
4. Captopril attenuates pressor responses to norepinephrine and vasopressin through depletion of endogenous angiotensin II.
Imai Y; Abe K; Seino M; Haruyama T; Tajima J; Yoshinaga K; Sekino H
Am J Cardiol; 1982 Apr; 49(6):1537-9. PubMed ID: 7041592
[TBL] [Abstract][Full Text] [Related]
5. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.
Kondowe GB; Copeland S; Passmore AP; Leahey WJ; Johnston GD
Eur J Clin Pharmacol; 1987; 32(3):229-35. PubMed ID: 3297732
[TBL] [Abstract][Full Text] [Related]
6. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives.
Fruncillo RJ; Rotmensch HH; Vlasses PH; Koplin JR; Swanson BN; Ferguson RK
Eur J Clin Pharmacol; 1985; 28(1):5-9. PubMed ID: 3886401
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenergic receptor sensitivity during sodium restriction and converting enzyme inhibition.
Mills P; Dimsdale J; Ziegler M; Brown M
Clin Exp Hypertens A; 1990; 12(2):179-90. PubMed ID: 2161301
[TBL] [Abstract][Full Text] [Related]
8. Captopril enhances vascular and adrenal responsiveness to angiotensin II in essential hypertension.
Koletsky RJ; Gordon MB; LeBoff MS; Moore TJ; Dluhy RG; Hollenberg NK; Williams GH
Clin Sci (Lond); 1984 Mar; 66(3):299-305. PubMed ID: 6362960
[TBL] [Abstract][Full Text] [Related]
9. Evidence for prejunctional inhibition of norepinephrine release by captopril in spontaneously hypertensive rats.
Antonaccio MJ; Kerwin L
Eur J Pharmacol; 1980 Nov; 68(2):209-12. PubMed ID: 7009166
[TBL] [Abstract][Full Text] [Related]
10. Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
Vierhapper H; Witte PU; Waldhäusl W
J Hypertens; 1986 Feb; 4(1):9-11. PubMed ID: 3007605
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II mediates hyperadrenergic activity evoked by sodium restriction in essential hypertension.
Mohara O; Masuyama Y
Life Sci; 1991; 49(13):939-45. PubMed ID: 1886454
[TBL] [Abstract][Full Text] [Related]
12. The opposing effects of chronic angiotensin-converting enzyme blockade by captopril on the responses to exogenous angiotensin II and vasopressin vs. norepinephrine in rats.
Spertini F; Brunner HR; Waeber B; Gavras H
Circ Res; 1981 May; 48(5):612-8. PubMed ID: 6260396
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin and angiotensin II pressor responsiveness: importance of dietary sodium.
Smyth DD; Fung HY
Eur J Pharmacol; 1984 Jun; 102(1):55-61. PubMed ID: 6383842
[TBL] [Abstract][Full Text] [Related]
14. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
Li P; Jackson EK
J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
[TBL] [Abstract][Full Text] [Related]
15. Influence of angiotensin converting enzyme inhibition with captopril on blood pressure and adrenergic function in normal and sodium restricted rats.
Sybertz EJ; Sabin CS; Moran R
Clin Exp Hypertens (1978); 1981; 3(5):1053-73. PubMed ID: 6269812
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
Lang CC; Stein CM; He HB; Wood AJ
Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
Uehlinger DE; Ferrier CP; Matthieu R; Reuter K; Gnaedinger MP; Saxenhofer H; Shaw S; Weidmann P
J Hypertens; 1989 Nov; 7(11):901-7. PubMed ID: 2558135
[TBL] [Abstract][Full Text] [Related]
18. [The pressor and adrenal responses to angiotensin II in patients with normoreninemic essential hypertension--the influence of sodium intake and captopril].
Kuroda K; Ito K; Sakaguchi A; Kimura G; Uda M; Kojima S; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T
Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):179-88. PubMed ID: 6353007
[No Abstract] [Full Text] [Related]
19. Angiotensin I- and II- and norepinephrine-mediated pressor responses in an ancient holostean fish, the bowfin (Amia calva).
Butler DG; Oudit GY; Cadinouche MZ
Gen Comp Endocrinol; 1995 Jun; 98(3):289-302. PubMed ID: 7628688
[TBL] [Abstract][Full Text] [Related]
20. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
